Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr-Jun;3(2):48-50.
doi: 10.4161/chim.21475. Epub 2012 Apr 1.

Chimerism in women with end stage renal diseases: Who's who?

Affiliations

Chimerism in women with end stage renal diseases: Who's who?

Laetitia Albano et al. Chimerism. 2012 Apr-Jun.

Abstract

Many sources of foreign or semi foreign cells, known as microchimerism (Mc), can be found in healthy individuals. We have recently shown in women with end stage renal disease (ESRD) that Mc frequencies and levels are exacerbated prior to kidney transplantation. Is Mc arising from pregnancy a protective factor for renal diseases explaining lower incidence in women? Is Mc helpful in slowing down disease progression? However, natural Mc is not the only actor as post blood transfusion Mc is also found at high levels in women with ESRD. The difficulty is therefore to distinguish the different types of Mc and this is made even more complicated when the recipient receives a potentially chimeric organ. What part does each source of chimerism play in disease and transplant fate, and can one decipher each role knowing that one chimerism may hide another?

PubMed Disclaimer

Figures

None
Figure 1. Diagram representing the possibilities for kidney transplantations and their associated chimerism sources. To make Mc transfer easier to understand, we have arbitrarily represented a gravid woman when the donor or the recipient is a woman, although the woman may be nulligravid and would then be identical to a man in terms of chimerism sources. Furthermore, to avoid complicating the diagram, we have not represented fraternal/gemellar and/or post transfusion Mc. In cases (A and B) the recipient is a woman, in cases (C and D) the recipient is a man. In cases (A and C) the donor is a woman, in cases (B and D) the donor is a man.

Comment on

  • Albano L, Rak JM, Azzouz DF, Cassuto-Viguier E, Gugenheim J, Lambert NC. Male microchimerism at high levels in peripheral blood mononuclear cells from women with end stage renal disease before kidney transplantation. PLoS One. 2012;7:e32248. doi: 10.1371/journal.pone.0032248.

Similar articles

References

    1. Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358:353–61. doi: 10.1056/NEJMoa071074. - DOI - PMC - PubMed
    1. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet. 2001;357:33–7. doi: 10.1016/S0140-6736(00)03569-8. - DOI - PubMed
    1. Ferlicot S, Vernochet A, Romana S, Ortin-Serrano M, Letierce A, Brégerie O, et al. Microchimerism in renal allografts: clinicopathological associations according to the type of chimeric cells. Histopathology. 2010;56:188–97. doi: 10.1111/j.1365-2559.2009.03466.x. - DOI - PubMed
    1. Koopmans M, Kremer Hovinga IC, Baelde HJ, de Heer E, Bruijn JA, Bajema IM. Endothelial chimerism in transplantation: Looking for needles in a haystack. Transplantation. 2006;82(Suppl):S25–9. doi: 10.1097/01.tp.0000231446.41051.98. - DOI - PubMed
    1. Pujal JM, Grinyó JM, Gil-Vernet S, Caldes A, Hernández P, Mestre M, et al. Early hematopoietic microchimerism predicts clinical outcome after kidney transplantation. Transplantation. 2007;84:1103–11. doi: 10.1097/01.tp.0000286172.57076.df. - DOI - PubMed